GlassScriptPhysician profile
Tina Tran Vu
NPI 1639632821
$851.71
in general payments reported to CMS, 2019-2025
16 companies · $263 in 2025
The $263 reported for 2025 was more than what 81% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $19.35 · 2023: $266 · 2024: $303 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $832.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $832.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $178.06 | 2022-2025 | Azstarys |
| Alkermes, INC. | $155.49 | 2023-2024 | Lybalvi, Vivitrol, Vivitrol |
| Otsuka America Pharmaceutical, INC. | $76.13 | 2023-2024 | Rexulti, Abilify Maintena |
| Tris Pharma INC | $74.76 | 2024-2025 | Dyanavel Xr, Quillivant |
| Organon LLC | $60.13 | 2024 | |
| Biogen, INC. | $57.81 | 2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $48.59 | 2023-2025 | Aptima, Fetal Fibronectin Enzyme Immunoassay |
| Merck Sharp & Dohme LLC | $46.93 | 2024-2025 | Gardasil 9, Gardasil, Vaxneuvance |
| Sanofi Pasteur INC. | $22.65 | 2023 | |
| Livanova USA, INC. | $22.63 | 2025 | Vns Therapy Symmetry Model 8103 Generator |
| Cipher Pharmaceuticals US LLC | $22.51 | 2025 | Natroba, Spinosad |
| Pfizer INC. | $20.99 | 2025 | |
| Verrica Pharmaceuticals INC. | $18.56 | 2024 | Ycanth |
| Ironshore Pharmaceuticals INC. | $16.61 | 2023 | Jornay Pm |
| Cumberland Pharmaceuticals, INC. | $15.15 | 2025 | Kristalose |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $14.71 | 2024 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tina Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.